The Institute of Molecular Biology of the Russian Academy of Sciences has developed a highly effective drug for COVID-19 COVID-19. This was announced by the director of the institute, Alexander Makarov, at a meeting with Russian President Vladimir Putin on the development of genetic technologies.
“Reduces the viral load a hundred thousand times”
According to Academician Makarov, the new drug was created “on the basis of monoclonal antibodies that neutralize coronavirus, including delta and gamma variants.” Monoclonal antibodies produced by immune cells can be obtained for almost any natural antigen and used to detect or purify it.
A dose of antibodies has been selected that reduces the viral load by a hundred thousand times, which is not inferior to the results of using the well-known American drug & quot ; Regeneron & quot;
Alexander Makarov
Makarov noted that the effectiveness of the new drug has been proven by laboratory tests, including on animals.
The first domestic drug
On November 13, it became known that the first domestic injection drug for the treatment of direct-acting coronavirus was registered in Russia. It is called Areplivir and will be admitted to hospitals by the end of 2021. This was announced by the developer company Promomed.
The first domestic direct-acting intravenous antiviral drug “Areplivir” (favipiravir) received a registration certificate and will be delivered to hospitals in all regions by the end of the year. With its development, Promomed Group of Companies responded to the urgent need of domestic health care for hospital COVID-19 therapy
Promomed company- drug developer
Full production and supply of the drug to Russian hospitals will begin in December 2021. It is noted that a multicenter clinical study of the drug led by Academician of the Russian Academy of Sciences Dmitry Pushkar confirmed the effectiveness and safety of the drug when used in hospitals.
According to the head of the Ministry of Health Mikhail Murashko, no country in the world has a cure for coronavirus … The minister stressed that a drug developed in Russia will be able to interrupt the course of COVID-19 at the initial stage of infection.
Related materials12: 50 – November 11 
COVID passports, green passes and QR codes. certificates00: 01 – October 25 
“Mild epidemic of dementia” Russians do not want to be vaccinated and comply with antikidny measures. What do doctors say about this?
In addition, earlier in November it became known that the Russian company Valenta Pharm had created its own drug for coronavirus – innoviron. Experts conducted the second phase of testing the drug back in June; 340 volunteers took part in 13 medical institutions. At the end of October this year, documents for registration of the development were sent.
According to Nikolay Bespalov, Development Director of RNC Pharma, Valenta Pharm will be able to position innovation as a drug against influenza and ARVI.
“ Mir-19 “
Another drug developed in Russia against the coronavirus, Mir-19, is completing the second phase of clinical trials. This was stated by the head of the Federal Medical and Biological Agency (FMBA) Veronika Skvortsova at the X anniversary international scientific and practical conference “Molecular Diagnostics – 2021”.
She recalled that Mir-19 belongs to the group of etiotropic antiviral drugs. It is intended to prevent or treat COVID-19 through inhalation or intranasal administration.
Skvortsova assured that the drug is safe and does not affect the human genome and immunity. At the same time, Mir-19 prevents the most severe forms of coronavirus development.
Morbidity dynamics in Russia
At the moment, there is a decrease in the incidence of COVID-19 in Russia. This assessment of the development of the coronavirus pandemic was given by the head of Rospotrebnadzor, Anna Popova, quoted by TASS.
The dynamics of a decrease in the growth in the number of patients with coronavirus infection is observed in ten Russian regions, Popova said. Over the past week, the incidence has decreased by 2.5 percent. The chief sanitary doctor also expressed hope that the situation with the coronavirus in the country will stabilize. At the same time, as Popova noted, among Russians over 60, the incidence is not decreasing. The head of Rospotrebnadzor called for organizing a vaccination campaign for this category of citizens as quickly as possible.
The fact that the situation with COVID-19 in Russia remains tense was previously stated by Prime Minister Mikhail Mishustin. He noted that in a number of regions it was possible to reduce the growth rate of morbidity due to the non-working day regime.